Inventor
HAN SANGDON
US41 patents
⚠️ This page may combine multiple inventors who share the name “HAN SANGDON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRINETICS PHARMACEUTICALS INC
18 patentsUS10696689B2Jun 30, 2020
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC12 citations86
US11186590B2Nov 30, 2021
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC6 citations84
US10981894B2Apr 20, 2021
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC6 citations84
US10766877B2Sep 8, 2020
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC7 citations84
US10604507B2Mar 31, 2020
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC7 citations84
US10562884B2Feb 18, 2020
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC7 citations84
US10351547B2Jul 16, 2019
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC9 citations84
US9902703B2Feb 27, 2018
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC8 citations84
US9896432B2Feb 20, 2018
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC11 citations84
US11834462B2Dec 5, 2023
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC2 citations73
US11566015B2Jan 31, 2023
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC2 citations73
US11414397B2Aug 16, 2022
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC2 citations73
US11072598B2Jul 27, 2021
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC6 citations73
US12479828B2Nov 25, 2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations62
US12492181B2Dec 9, 2025
Gem-disubstituted piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52
US12479825B2Nov 25, 2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52
US12466829B2Nov 11, 2025
Spirocyclic piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52
US11028068B2Jun 8, 2021
Somatostatin modulators and uses thereof
CRINETICS PHARMACEUTICALS INC0 citations52
ARENA PHARM INC
15 patentsUS9328107B2May 3, 2016
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
USRE45336EJan 13, 2015
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
US9126932B2Sep 8, 2015
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC17 citations91
US10981895B2Apr 20, 2021
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
ARENA PHARM INC4 citations84
US10183930B2Jan 22, 2019
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
ARENA PHARM INC10 citations84
US10632134B2Apr 28, 2020
Cannabinoid receptor modulators
ARENA PHARM INC5 citations83
US9867822B2Jan 16, 2018
Cannabinoid receptor modulators
ARENA PHARM INC7 citations83
US9522133B2Dec 20, 2016
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC9 citations83
US9492447B2Nov 15, 2016
Cannabinoid receptor modulators
ARENA PHARM INC9 citations83
US11771695B2Oct 3, 2023
Cannabinoid receptor modulators
ARENA PHARM INC4 citations74
US11560369B2Jan 24, 2023
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
ARENA PHARM INC2 citations73
US11214548B2Jan 4, 2022
Cannabinoid receptor modulators
ARENA PHARM INC3 citations72
US12109219B2Oct 8, 2024
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US11746091B2Sep 5, 2023
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US9987252B2Jun 5, 2018
Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations62
JONES ROBERT M
3 patentsUS8778950B2Jul 15, 2014
Cannabinoid receptor modulators
JONES ROBERT M21 citations92
US8580841B2Nov 12, 2013
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
JONES ROBERT M21 citations92
US9944606B2Apr 17, 2018
Cannabinoid receptor modulators
JONES ROBERT M3 citations72
TEEGARDEN BRADLEY
2 patentsUS8664258B2Mar 4, 2014
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY14 citations91
US8148417B2Apr 3, 2012
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY21 citations91